Clifford Swan Investment Counsel LLC boosted its position in shares of Albemarle Co. (NYSE:ALB – Free Report) by 0.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 101,258 shares of the specialty chemicals company’s stock after purchasing an additional […]
Albemarle (NYSE:ALB – Get Free Report) had its target price hoisted by Royal Bank of Canada from $138.00 to $157.00 in a report released on Monday, Benzinga reports. The brokerage currently has an “outperform” rating on the specialty chemicals company’s stock. Royal Bank of Canada’s target price would suggest a potential upside of 20.62% from […]
Albemarle Co. (NYSE:ALB – Get Free Report) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 13,730,000 shares, a decrease of 6.2% from the March 31st total of 14,630,000 shares. Based on an average daily trading volume, of 3,390,000 shares, the days-to-cover ratio […]
Atria Wealth Solutions Inc. increased its stake in Albemarle Co. (NYSE:ALB – Free Report) by 10.2% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 16,801 shares of the specialty chemicals company’s stock after purchasing an additional 1,551 shares during the period. Atria Wealth Solutions Inc.’s […]
Van ECK Associates Corp raised its position in Albemarle Co. (NYSE:ALB – Free Report) by 4,471.9% during the fourth quarter, HoldingsChannel reports. The firm owned 332,100 shares of the specialty chemicals company’s stock after buying an additional 324,836 shares during the quarter. Van ECK Associates Corp’s holdings in Albemarle were worth $47,982,000 as of its […]